Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: A controlled randomized study

International Journal of Gynecological Cancer

Volumn 19, Issue 5, 2009, Pages 873-878

  Sorbe, Bengt ^a   Nordström, Britta ^b   Mäenpää, Johanna ^c   Kuhelj, Janez ^d   Kuhelj, Dimitrij ^e   Okkan, Sait ^f   Delaloye, Jean Francois ^g   Frankendal, B ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d doo   (Slovenia)

^e UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^f ISTANBUL UNIVERSITY   (Turkey)

^g Department of Gynecology and Obstetrics ^*  (Switzerland)

Author keywords

Brachytherapy; Endometrial carcinoma; Low risk; Vaginal irradiation

Indexed keywords

CESIUM 137; IRIDIUM 192; CESIUM; COBALT; IRIDIUM;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; COBALT THERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTANT METASTASIS; DYSURIA; ENDOMETRIUM CARCINOMA; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; TREATMENT DURATION; URINARY FREQUENCY; URINE INCONTINENCE; VAGINA ATROPHY; VAGINA BLEEDING; VAGINAL DRYNESS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIATION DOSE FRACTIONATION; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, ENDOMETRIOID; CESIUM RADIOISOTOPES; COBALT RADIOISOTOPES; DOSE FRACTIONATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IRIDIUM RADIOISOTOPES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 69449098469     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a6c9df     Document Type: Article

References (44)

1. Cancer Incidence in Sweden 2005. Official Statistics of Sweden. Stockholm: National Board of Health and Welfare, Centre for Epidemiology; 2007.
2. Ng TY, Perrin LC, Nicklin JL, et al. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy. Gynecol Oncol. 2000;79:490-494.
3. Mandell L, Nori D, Anderson L, et al. Postoperative vaginal radiation in endometrial cancer using a remote afterloading technique. Int J Radiat Oncol Biol Phys. 1985;11:473-478.
4. Sorbe BG, Smeds AC. Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I. Int J Radiat Oncol Biol Phys. 1990;18:305-314.
5. Elliott P, Green D, Coates A, et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer. 1994;4:84-93.
6. Hansgen G, Nagel M, Dunst J, et al. Postoperative radiotherapy in endometrial carcinoma. A retrospective analysis of 541 cases. Strahlenther Onkol. 1999;175:548-553.
7. Horowitz NS, Peters WA 3rd, Smith MR, et al. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol. 2003;99:235-240.
8. Alektiar KM, McKee A, Venkatraman E, et al. Intravaginal highdose- rate brachytherapy for stage IB (FIGO grade 1, 2) endometrial cancer. Int J Radiat Oncol Biol Phys. 2002;53:707-713.
9. Peiffert D, Hoffstetter S, Charra-Brunaud C. Brachytherapy of endometrial cancers. Cancer Radiother. 2003;7:121-131.
10. Sorbe B, Straumits A, Karlsson L. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels. Int J Radiat Oncol Biol Phys. 2005;62: 1385-1389.
11. Salihoǧlu Y, Keskin H, Topuz S, et al. Analysis of vaginal recurrences in stage I endometrial adenocarcinoma. Eur J Gynaecol Oncol. 2007;28: 313-315.
12. Röper B, Astner ST, Heydemann-Obradovic A, et al. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients. Gynecol Oncol. 2007;107:541-548.
13. Martinez-Monge R, Nagore G, Cambeiro M, et al. Intravaginal 1-week high-dose-rate brachytherapy alone for stages I-II endometrial cancer. Brachytherapy. 2007;6:195-200.
14. Solhjem MC, Petersen IA, Haddock MG. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:1379-1384.
15. McCormick TC, Cardenes H, Randall ME. Early-stage endometrial cancer: is intravaginal radiation therapy alone sufficient therapy? Brachytherapy. 2002;1:61-65.
16. Ackerman I, Malone S, Thomas G, et al. Endometrial carcinomaVrelative effectiveness of adjuvant irradiation vs. therapy reserved for relapse. Gynecol Oncol. 1996;60:177-183.
17. Greven KM, D'Agostino RB Jr, Lanciano RM, et al. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer? Int J Radiat Oncol Biol Phys. 1998;42:101-104.
18. Jereczek-Fossa BA. Postoperative irradiation in endometrial cancer: still a matter of controversy. Cancer Treat Rev. 2001;27:19-33.
19. Hogberg T, Fredstorp-Lidebring M, Alm P, et al. A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer. Int J Gynecol Cancer. 2004;14:437-450.
20. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, et al. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008;83:97-112.
21. Högberg T, Rosenberg P, Kristensen G, et al. A randomized phase-III study on adjuvant treatment with radiation (RT) T chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). 2007 ASCO Annual Meeting Proceedings Part 1. J Clin Oncol. 2007;25:5503.
22. Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol. 1980;56:419-427.
23. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Lancet. 2000;355:1404-1411.
24. Scholten AN, van Putten WL, Beerman H, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys. 2005;63:834-838.
25. Nag S, Erickson B, Parikh S, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 2000;48:779-790. (Pubitemid 30742652)
26. Small W Jr, Erickson B, Kwakwa F. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int J Radiat Oncol Biol Phys. 2005;63:1502-1507.
27. Keys HM, Roberts JA, Brunetto VL, et al.Aphase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-751.
28. ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373: 137-146.
29. Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: results of the randomized PORTEC-2 trial. 2008 ASCO Annual Meeting Proceedings [abstract LBA5503]. J Clin Oncol. 2008;26293s. Part I of II.
30. Withers HR, Thames HD, Peters LJ. A new isoeffect curve for change in dose per fraction. Radiother Oncol. 1983;1:187-191.
31. Jolly S, Vargas C, Kumar T, et al. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol. 2005;97:887-892.
32. Alektiar KM, Venkatraman E, Chi DS, et al. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:111-117.
33. Himmelmann A, Notter G, Turesson I. Normal tissue reactions to high dose-rate intracavitary irradiation of the vagina with different fractionation schedules and dose levels. Strahlenther. 1985;161: 163-167.
34. Kim RY, Pareek P, Duan J, et al. Postoperative intravaginal brachytherapy for endometrial cancer; dosimetric analysis of vaginal colpostats and cylinder applicators. Brachytherapy. 2002;1:138-144.
35. Li S, Aref I, Walker E, et al. Effects of prescription depth, cylinder size, treatment length, tip space, and curved end on doses in high-dose-rate vaginal brachytherapy. Int J Radiat Oncol Biol Phys. 2007;67: 1268-1277.
36. Fayed A, Mutch DG, Rader JS, et al. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2007;67:480-484.
37. Onsrud M, Strickert T, Marthinsen AB. Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer: a comparison of standardized and individualized target volumes. Int J Radiat Oncol Biol Phys. 2001;49:749-755.
38. Van Geelen JM, van deWeijer PH, Arnolds HT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:9-14.
39. Naumann RW, Coleman RL. The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005. Gynecol Oncol. 2007;105:7-12.
40. Lahance JA, Stukenborg GJ, Schneider BF, et al. A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma. Gynecol Oncol. 2008;108:77-83.
41. Fanning J, Hoffman ML, Andrews SJ, et al. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation. Gynecol Oncol. 2004;93: 632-636.
42. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol. 1990;38:99-104.
43. Touboul E, Belkacemi Y, Buffat L, et al. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients. Int J Radiat Oncol Biol Phys. 2001;50:81-97.
44. Pustilnik T, Burke TW. Adjuvant chemotherapy for high-risk endometrial cancer. Semin Radiat Oncol. 2000;10:23-28.